Termed the Translational Academic Research Partnership.

Calibr, JDRF partner to research on promising type 1 diabetes therapeutic targets The California Institute for Biomedical Research and JDRF announced a partnership today to apply Calibr's drug discovery expertise to type 1 diabetes research projects in collaboration with academic investigators from JDRF's network. Termed the Translational Academic Research Partnership, the jointly funded Calibr-JDRF system will establish collaborative tasks centered on promising type 1 diabetes therapeutic targets and the discovery of early drug network marketing leads for validation and follow-on development.Based on our technology of integrating heat shock proteins with antigenic peptides, we could create therapeutic vaccines for many infectious diseases potentially. Our next step is to engage a partner to advance the clinical development of AG-707 in genital herpes and to pursue the broader program of the platform technology, added Garo Armen, PhD, Antigenics CEO and chairman. Sufferers received three treatments at two-week intervals. The vaccine was well tolerated, with injection site pain as the most typical reported adverse event.

Other entries from category "nutrition":

Random entries